Free Trial

Brooklands Fund Management Ltd Makes New Investment in Lam Research Corporation $LRCX

Lam Research logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Brooklands Fund Management acquired 142,800 Lam Research shares worth approximately $46.9 million, making LRCX its second-largest holding at 6.9% of the portfolio. Institutional investors collectively own 84.61% of the company.
  • Lam Research exceeded quarterly expectations with $2.20 adjusted EPS and $8.22 billion in revenue, up 54.4% year over year. Management’s outlook for roughly $8.60 billion in next-quarter revenue supports continued semiconductor-equipment demand.
  • Analysts maintain a generally positive view, with a “Moderate Buy” consensus and an average price target of $360.23, though insider selling and potential supply constraints remain risks.
  • MarketBeat previews top five stocks to own in December.

Brooklands Fund Management Ltd acquired a new stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 142,800 shares of the semiconductor company's stock, valued at approximately $46,911,000. Lam Research makes up about 6.9% of Brooklands Fund Management Ltd's investment portfolio, making the stock its 2nd largest holding.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. World Equity Group Inc. increased its stake in shares of Lam Research by 0.5% during the second quarter. World Equity Group Inc. now owns 5,576 shares of the semiconductor company's stock worth $2,416,000 after purchasing an additional 29 shares in the last quarter. Vann Equity Management LLC raised its position in shares of Lam Research by 1.1% during the 3rd quarter. Vann Equity Management LLC now owns 2,873 shares of the semiconductor company's stock worth $944,000 after purchasing an additional 31 shares during the last quarter. Tenzing Financial LLC lifted its stake in Lam Research by 3.5% in the 2nd quarter. Tenzing Financial LLC now owns 1,018 shares of the semiconductor company's stock valued at $441,000 after buying an additional 34 shares in the last quarter. Advus Financial Partners LLC lifted its stake in Lam Research by 1.0% in the 2nd quarter. Advus Financial Partners LLC now owns 3,578 shares of the semiconductor company's stock valued at $1,550,000 after buying an additional 34 shares in the last quarter. Finally, Paragon Private Wealth Management LLC lifted its stake in Lam Research by 1.3% in the 2nd quarter. Paragon Private Wealth Management LLC now owns 2,719 shares of the semiconductor company's stock valued at $1,178,000 after buying an additional 35 shares in the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Lam Research

In other news, Director Bethany Mayer sold 9,557 shares of the business's stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $314.74, for a total transaction of $3,007,970.18. Following the transaction, the director directly owned 20,995 shares in the company, valued at $6,607,966.30. The trade was a 31.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Ava Harter sold 5,000 shares of the company's stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $302.46, for a total value of $1,512,300.00. Following the completion of the sale, the insider owned 42,462 shares of the company's stock, valued at $12,843,056.52. This trade represents a 10.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.31% of the company's stock.

Lam Research Stock Performance

NASDAQ:LRCX opened at $254.39 on Friday. The company has a market cap of $317.78 billion, a P/E ratio of 37.55, a P/E/G ratio of 0.94 and a beta of 1.85. Lam Research Corporation has a twelve month low of $135.50 and a twelve month high of $438.50. The company's 50-day moving average price is $295.90 and its 200-day moving average price is $283.68. The company has a current ratio of 2.48, a quick ratio of 1.86 and a debt-to-equity ratio of 0.27.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The semiconductor company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.18 by $0.02. Lam Research had a net margin of 32.34% and a return on equity of 72.15%. The company had revenue of $8.22 billion during the quarter, compared to analysts' expectations of $8.14 billion. During the same quarter in the prior year, the company earned $1.26 EPS. Lam Research's revenue was up 54.4% compared to the same quarter last year. On average, sell-side analysts forecast that Lam Research Corporation will post 9.59 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd were issued a dividend of $0.33 per share. The ex-dividend date was Wednesday, September 23rd. This represents a $1.32 annualized dividend and a dividend yield of 0.5%. This is an increase from Lam Research's previous quarterly dividend of $0.26. Lam Research's payout ratio is presently 19.67%.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research reported fiscal first-quarter revenue of $8.22 billion and adjusted EPS of $2.20, exceeding analyst expectations. Management’s outlook for approximately $8.60 billion in the December quarter, along with expected EPS of about $2.33, reinforced the view that demand remains robust. Lam Research Gains as Strong Earnings and a Chip-Sector Rebound Support Shares
  • Positive Sentiment: Record foundry revenue in fiscal 2027’s first quarter, with foundry rising to 46% of Systems revenue from 44%, points to continued spending on advanced semiconductor manufacturing. Lam Research Sees Record Foundry Sales: Can the Momentum Continue?
  • Positive Sentiment: SK Hynix’s expectation that memory shortages could persist through 2030 is fueling hopes for years of fab construction and sustained orders for equipment makers, including LRCX. The broader chip-sector rebound has added momentum. Chip Equipment Stocks Rally as SK Hynix Signals Memory Shortage Into 2030
  • Positive Sentiment: Analyst coverage continues to emphasize AI infrastructure demand, rising chip complexity and projected 2026 systems-revenue growth above 40%. Some market commentary also describes LRCX as attractively valued relative to its earnings-growth outlook. Top Analyst Reports for Lam Research, Lockheed Martin & Equinor
  • Neutral Sentiment: Investor attention remains unusually high, while institutional activity was mixed: more funds added LRCX shares than reduced positions in the latest reported quarter. This signals interest but does not establish a clear near-term price direction. Lam Research Corporation Is Attracting Investor Attention
  • Negative Sentiment: Supply constraints may prevent Lam Research from fully converting strong demand into near-term revenue growth, creating execution risk despite favorable industry trends. Lam Research Stock: Supply Constraints Limit Growth
  • Negative Sentiment: Reported insider transactions show substantial selling and no purchases over the past six months. While sales may reflect diversification or scheduled transactions, the pattern can weigh on sentiment.

Analyst Upgrades and Downgrades

Several research firms have commented on LRCX. Jefferies Financial Group set a $335.00 price objective on Lam Research and gave the stock a "buy" rating in a research note on Thursday, July 30th. HSBC reissued a "hold" rating and set a $333.00 target price on shares of Lam Research in a report on Monday, July 27th. Citigroup restated a "buy" rating and issued a $435.00 target price (down from $450.00) on shares of Lam Research in a research report on Thursday, October 22nd. Morgan Stanley set a $339.00 price target on Lam Research and gave the stock an "overweight" rating in a research note on Thursday, October 22nd. Finally, Fundamental Research set a $390.00 price target on Lam Research in a research report on Thursday, October 1st. Twenty-six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $360.23.

Check Out Our Latest Research Report on LRCX

Lam Research Profile

(Free Report)

Lam Research Corporation NASDAQ: LRCX is a semiconductor equipment company that develops and manufactures systems used to fabricate integrated circuits. Its technologies support key stages of wafer processing, helping semiconductor manufacturers create the increasingly complex structures found in memory, logic and other types of chips.

The company's product portfolio includes etch systems, which selectively remove materials from wafers; deposition systems, which apply thin films; and cleaning solutions used to remove contaminants and residue during manufacturing.

Featured Articles

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines